Bhatnagar Anish, CHIEF EXECUTIVE OFFICER at SOLENO THERAPEUTICS INC (SLNO), sold 37,960 shares at $41.67 ($1.6M) on 2024-04-01, disclosed to the SEC on 2024-04-03.
Open-market sale of $1.6M SLNO by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.12 | 11,383 | $468K | 29.8% |
| 2 | $41.12 | 11,383 | $468K | 29.8% |
| 3 | $41.67 | 7,597 | $317K | 20.2% |
| 4 | $41.67 | 7,597 | $317K | 20.2% |
| Total | $41.34 avg | 37,960 | $1.6M | 100% |
| Filing → |
| SLNO | SELL | 2024-10-03 | $2.0M | — | Filing → |
| SLNO | SELL | 2024-08-30 | $10.9M | — | Filing → |
| SLNO | SELL | 2024-08-07 | $11.6M | — | Filing → |